Wuhan Ammunition Life-tech Co., Ltd (WALT) was established in January 2015. It is a high-tech enterprise specialising in the research, development, production and sale of early non-invasive detection products for high-incidence malignant tumours. The company headquarter is located in Wuhan City, with six branch offices across China.

By combining epigenetics, bioinformatics, clinical big data and artificial intelligence analysis, WALT has developed a new generation of cancer detection technology based on methylation liquid biopsy. This has resulted in the launch of a series of products covering digestive system tumours, gynaecological tumours, urinary system tumours and pan-cancer. In line with our mission to “detect cancer at an early stage when it can be cured”, WALT is dedicated to offering early, accurate, convenient and universal cancer screening solutions.